Endogenous SORLA was found to localize largely to early endosomes (identified by EEA1 and Rab5 expression) and retrograde vesicles (VPS35) in MDA-MB-361 breast cancer cells (Supplementary Fig. 1c). Here, RAB5A is linked to breast cancer.